Gene-Edited Wheat Reduces Carcinogenic Acrylamide in Toasted Bread

Researchers at Rothamsted Research in Harpenden, Hertfordshire, have developed a new strain of wheat using CRISPR gene-editing technology, which significantly reduces the formation of acrylamide, a probable carcinogen, when bread is toasted. This innovation addresses a critical food safety concern, as acrylamide is produced from the amino acid free asparagine during high-temperature cooking processes such as baking and frying.

The Guardian

Field trials conducted over two years demonstrated that the CRISPR-edited wheat can lower free asparagine levels by up to 93% without compromising crop yields. In contrast, conventional methods that induce random mutations through chemical agents achieved only a 50% reduction in free asparagine but resulted in a nearly 25% decrease in yield due to unintended genetic changes.

The Guardian

The findings suggest that bread and biscuits made from this gene-edited wheat could have substantially lower acrylamide levels, with some samples falling below detectable limits even after toasting. Dr. Navneet Kaur, a lead researcher, emphasized the potential of CRISPR technology to create precise, beneficial changes in crop genetics, stating, “This work demonstrates the power of Crispr technology to deliver precise, beneficial changes in crop genetics.”

The Guardian

The UK has positioned itself as a leader in gene editing research following Brexit, which removed EU regulations on genetically modified organisms. The Genetic Technology (Precision Breeding) Act, passed in 2023, facilitates the development and marketing of genetically modified crops and livestock, potentially enhancing food safety standards.

The Guardian

Despite these advancements, the future of gene-edited crops in the UK may face challenges due to ongoing negotiations regarding a new sanitary and phytosanitary (SPS) agreement with the EU. If the EU successfully mandates alignment with its food regulations, it could hinder the adoption of precision-bred crops in the UK. Additionally, the EU has stringent regulations on acrylamide levels in food, which could impact the export of UK products.

The Guardian

Prof. Nigel Halford, who led the study, noted that “low-acrylamide wheat could enable food businesses to meet evolving safety standards without compromising product quality or incurring major production costs.” This highlights the dual benefit of improving food safety while maintaining economic viability for producers.

The Guardian

The development of CRISPR-edited wheat represents a significant advancement in agricultural biotechnology, with the potential to enhance food safety by reducing carcinogenic compounds in commonly consumed products. However, the regulatory landscape and international agreements will play a crucial role in determining the future of such innovations in the UK and beyond.

The Guardian